BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26101993)

  • 21. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propranolol Use for Infantile Hemangiomas.
    Ryan J
    Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Ultrasonographic Evaluation of Infantile Periocular Hemangioma Treated With Oral Propranolol.
    Jamshidian-Tehrani M; Nabavi A; Taghavi M; Sharif-Kashani S; Kasaee A; Sadeghi-Tari A; Mirhosseini M; Nowroozzadeh MH
    Ophthalmic Plast Reconstr Surg; 2019; 35(5):484-486. PubMed ID: 30844918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
    Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
    Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe infantile haemangioma: complications and treatment.
    Heaton P; Kennedy C; Amin S
    J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
    [No Abstract]   [Full Text] [Related]  

  • 32. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
    Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
    J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
    Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
    J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol for orbital hemangioma.
    Taban M; Goldberg RA
    Ophthalmology; 2010 Jan; 117(1):195-195.e4. PubMed ID: 20114117
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
    Léauté-Labrèze C; Taïeb A
    Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.
    Schupp CJ; Kleber JB; Günther P; Holland-Cunz S
    Pediatr Dermatol; 2011; 28(6):640-644. PubMed ID: 21995836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
    Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
    J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
    Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
    Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol for the treatment of orbital infantile hemangiomas.
    Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
    Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.